NASDAQ$CERS

Cerus Corp · Q4 2025 earnings

Q4 2025 earnings · · After market close · Investor relations

Briefing

CERS reported Q4 2025, revenue of $64.6M, a net loss of $2.2M, diluted EPS of $-0.01.

For Q4 2025, CERS reported revenue of $64.6M, a net loss of $2.2M, diluted EPS was $-0.01. Management discusses segment performance, capital allocation, and macro risks in the quarterly filing.

  • Revenue $64.6M.
  • Net loss $2.2M.
  • Diluted EPS $-0.01.

Headline financials

Total Revenue

$64.6M

Previous: $56.8M+13.8%
EPS (adj)

-$0.01

Previous: -$0.01+0.0%
Product Gross Margin

51.5%

Previous: 53.9%-4.5%
Adjusted EBITDA

$3.36M

Previous: $3.27M+2.7%
Operating Cash Flow

$6.2M

Previous: $4.9M+26.5%
Worldwide Platelet Kit Growth

0.0%

No prior period
Worldwide Dose Growth

-1.0%

No prior period
U.S. IFC Sales

$4.2M

Previous: $3M+40.0%
Net Income

-$2.2M

Previous: -$2.56M+14.1%
Operating Income

-$641K

Previous: -$1.45M+55.8%
Gross Profit

$29.7M

Previous: $27.4M+8.6%

Revenue & EPS history

Cerus · Revenue · Quarterly

$64.6M

Q4 2025+13.8%vs Q4 2024
Beat estimate in 6 of 14 quarters(43%)
ActualEstimate

Revenue by segment

Cerus · $47.3M total across 2 segments · Q3 2023

  • Product Revenue
    $39.8M+0.5%
  • Government Contract Revenue
    $7.48M+10.4%

Forward guidance

The quarterly filing discusses operating priorities, capital returns, and sector risks.

Tailwinds

  • MD&A highlights liquidity and core business trends.
  • Segment commentary supports the earnings narrative.

Headwinds

  • Macro or input-cost pressure may affect margins.
  • One-time items can affect YoY comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

-0.4%

Avg return

Earnings day

+1.0%

Avg return

5 days after

-0.8%

Avg return

30 days after

48%

31 / 65 earnings

Positive

+27.5%

Q3 2017

Best reaction

-19.6%

Q1 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+5.7%+34.9%+58.3%
Q4 2025-17.3%-23.7%-26.5%
Q3 2025-2.8%+0.0%+21.4%
Q2 2025+0.8%-2.3%+3.9%
Q1 2025+2.3%+0.0%-2.3%
Q4 2024-5.2%-5.7%-12.1%
Q3 2024-7.6%-8.2%+8.8%
Q1 2024-5.8%+7.6%+4.1%
Q4 2023+14.2%+6.6%-10.8%
Q3 2023+25.4%+25.4%+21.0%
Q2 2023-17.8%-26.3%-35.4%
Q1 2023-0.9%-6.1%-1.7%
Q4 2022-7.0%+2.1%-1.4%
Q3 2022+7.7%+6.0%+18.9%
Q2 2022-4.5%-12.7%-32.8%
Q1 2022+2.9%-2.7%-2.3%
Q4 2021-2.1%+8.6%+3.6%
Q3 2021+14.5%+16.0%+1.5%
Q2 2021+21.1%+21.9%+28.2%
Q1 2021+2.7%+4.8%-7.7%
Q4 2020-8.6%-3.9%-11.3%
Q3 2020-5.4%-0.4%+18.6%
Q2 2020-1.8%-4.7%-17.7%
Q1 2020+2.1%+5.2%+12.5%
Q4 2019-1.0%-6.0%-39.2%
Q3 2019-4.4%-3.7%-4.6%
Q2 2019-8.7%-13.5%-8.2%
Q1 2019-12.3%-15.2%-27.3%
Q4 2018+2.8%+6.5%-3.7%
Q3 2018-4.9%-13.4%-21.6%
Q2 2018-5.9%-4.8%+4.1%
Q1 2018+11.9%+17.1%+17.8%
Q4 2017+2.1%+7.5%+9.0%
Q3 2017+27.5%+26.4%+40.9%
Q2 2017+3.6%+7.1%+6.7%
Q1 2017-19.6%-28.3%-44.5%
Q4 2016-7.8%+5.0%+0.7%
Q3 2016+6.4%+15.0%+10.2%
Q2 2016+1.8%-4.5%-11.3%
Q1 2016-6.6%
Q4 2015+0.5%
Q3 2015+4.5%
Q2 2015-2.5%
Q1 2015+0.3%
Q4 2014-12.7%
Q3 2014-5.8%
Q2 2014+4.8%
Q1 2014+4.4%
Q4 2013-15.7%
Q3 2013-6.1%
Q2 2013+6.7%
Q1 2013-9.7%
Q4 2012+14.0%
Q3 2012-1.9%
Q2 2012-2.7%
Q1 2011+0.5%
Q1 2012+1.5%
Q4 2009+0.8%
Q4 2011+0.8%
Q3 2010+1.4%
Q3 2011+1.4%
Q2 2010-2.8%
Q2 2011-2.8%
Q4 2010-2.8%
Q1 2010-2.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro